CuraScientific (CSTF) AI Stock Analysis
Top Page
CuraScientific
(Other OTC:CSTF)
No summary available
CuraScientific (CSTF) vs. SPDR S&P 500 ETF (SPY)
Not enough price history over this period.
- Market Cap
- $377.35K
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 0.0
- Beta (1Y)
- 142.21
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 2
- Sector
- General
- Sector Strength
- 55
- Industry
- Drug Manufacturers - Specialty & Generic
CuraScientific Business Overview & Revenue Model
Company Description
Based in Coachella, California, CuraScientific Corp. was founded in 2020. The company focuses on the production, distribution, and retail of cannabis products, which are sold under the JW Brands and Chad Enterprises names. In addition to cannabis, it...
CuraScientific Peers Comparison
Overall Rating
NCEL42Neutral
SCNI41Neutral
PRFX38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 42Neutral | $13.73M | 7.73 | 21.75% | ― | ― | ― | |
| 41Neutral | $268.82K | 0.00 | -26.63% | ― | 30.12% | -165.46% | |
| 38Underperform | $2.22M | -0.07 | -72.87% | ― | ― | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CSTF | Curascientific Corp | ― | ― | ― | |
| SCNI | Scinai Immunotherapeutics Ltd. Sponsored Adr | 0.47 | -12.23 | -96.29% | |
| PRFX | Painreform Ltd. | 0.73 | -5.07 | -87.41% | |
| NCEL | Newcelx Ltd. | 2.55 | -2.59 | -50.39% | |
| AKAN | Akanda Corp | 1.04 | -34.29 | -97.06% | |
| CDT | Cdt Equity Inc. | 0.07 | -15624.93 | -100.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.